Phthalic acid, tetrabromo-, disodium salt 25357-79-3 Tetrabromophthalic acid,sodium salt;_x000D_ 1,2-Benzenedicarboxylic acid,3,4,5,6-tetrabromo-,disodium salt;_x000D_ disodium tetrabromophthalate;

2,6-difluoro-benzylzinc bromide 307496-33-9 1,3-difluoro-2-methanidylbenzene;_x000D_ 2,6 difluorobenzylzinc bromide;_x000D_ 2,5-DIFLUORO-L-PHENYLALANINE;_x000D_ (2,6-difluorobenzyl)zinc (II) bromide;_x000D_ 2,6-DIFLUOROBENZYLZINC BROMIDE;_x000D_ bromozinc(1+);

N,N'-di-L-alanyl-L-cystine 115888-13-6 N,N'-Di-L-alanyl-L-cystin;_x000D_ L-alanyl-l-cystine;_x000D_ N,N'-bis-L-alanyl-L-cystine;

Aspirin 50-78-2 2-Acetoxybenzoic acid,O-Acetylsalicylic acid,ASA;_x000D_ ECM;_x000D_ ASA;_x000D_ O-acetyl salicylic acid;_x000D_ O-Acetylsalicylic acid;_x000D_ ronal;_x000D_ Acetylsalicylic acid;_x000D_ Novid;_x000D_ Bayer;_x000D_ 2-(acetyloxy)benzoic acid;_x000D_ 2-Acetoxybenzoic acid;_x000D_ Aspr;_x000D_ aspirin;_x000D_ Aspec;_x000D_ 2-Acetoxybenzoic acid,O-Acetylsalicyl;_x000D_ Benzoic acid, 2-(acetyloxy)-;_x000D_ Adiro;_x000D_ Aspro;_x000D_ Xaxa;

methyl-tris(phenylmethoxy)silane 61214-13-9 EINECS 262-663-4;

Sodium bis(perfluorobutanesulfonyl)imide 129135-86-0 Sodium nonafluoro-N-[(nonafluorobutyl)sulfonyl]-1-butanesulfonamide;_x000D_ 1-Butanesulfonamide, 1,1,2,2,3,3,4,4,4-nonafluoro-N-[(nonafluorobutyl)sulfonyl]-, sodium salt (9CI);_x000D_ 1-Butanesulfonamide, 1,1,2,2,3,3,4,4,4-nonafluoro-N-[(1,1,2,2,3,3,4,4,4-nonafluorobutyl)sulfonyl]-, sodium salt (1:1);_x000D_ Bisperfluorobutanesulfonylimide, sodium salt;_x000D_ EF-N 443;

4-Hydroxy-3-nitropyridine 5435-54-1 3-NITRO-4-PYRIDINOL;_x000D_ 4-HYDROXY-3-NITROPRIDINE;_x000D_ 3-nitro-4-idrossipiridina;_x000D_ 3-nitro-4-hydroxypyridine;_x000D_ 4-Pyridinol,3-nitro-(6CI,7CI,9CI);_x000D_ 3-nitro-4-pyridone;_x000D_ 4-hydroxy-3-nitropytidine;_x000D_ 3-nitropyridin-4-ol;

2-hydroxyhexacosyl 12-hydroxyoctadecanoate 93840-69-8 EINECS 298-934-9;

4-aminobenzenesulfonic acid,benzene-1,3-diol,2,4-dimethylaniline 94552-14-4 Reaction product of diazotized sulfanilic acid,diazotized xylidine and resorcinol;_x000D_ EINECS 305-459-3;_x000D_ Benzenesulfonic acid,4-amino-,diazotized,coupled with diazotized xylidine and resorcinol;

NADH 58-68-4 Dihydrocoenzyme I;_x000D_ REDUCED BETA-NICOTINAMIDE ADENINE DINUCLEOTIDE;_x000D_ Reduced nicotinamide-adenine dinucleotide;